HIV Post-Exposure Prophylaxis (PEP): What It Is, When to Start & What to Expect
PEP is a 28-day course of antiretroviral drugs started after potential HIV exposure to prevent infection.
Who Needs PEP
High-risk exposures within the last 72 hours:
- Condomless anal/vaginal sex with HIV+ partner (or unknown status, high prevalence setting)
- Needle-sharing with HIV+ person
- Needlestick injury (healthcare)
- Sexual assault
- Exposure to blood/body fluids on mucous membranes/broken skin
Low-risk: oral sex, biting, splashes to intact skin — PEP generally not recommended
Critical Window
- Start ASAP — ideally within 2 hours, no later than 72 hours
- Every hour of delay reduces efficacy
- After 72 hrs, PEP not recommended (but seek testing/counseling)
Standard Regimen (US Guidelines)
- Preferred: Tenofovir disoproxil fumarate/emtricitabine (Truvada) + raltegravir or dolutegravir
- Alternative: TAF/FTC (Descovy) + integrase inhibitor
- Duration: 28 days
Effectiveness & Side Effects
- Reduces infection risk by >80% (observational data)
- Not 100% — failures occur with delayed start, resistance, non-adherence
- Common side effects: nausea, headache, fatigue, diarrhea (usually mild, transient)
- Rare: liver toxicity, renal impairment (monitor labs at baseline, 2 wks, 4 wks)
Follow-Up
- HIV testing at baseline, 4–6 weeks, 3 months, 6 months
- STI screening, pregnancy test if applicable
- PrEP discussion for ongoing risk
- Mental health support
Go to an ER or sexual health clinic immediately after exposure. Do not wait for an appointment.
HIV & AIDS - Related Articles
- Understanding HIV: A Retrovirus Explained
- Understanding HIV: Virus Size Compared to Bacteria and Other Germs
- Understanding HIV/AIDS: Symptoms, Treatment, and Prevention
- Understanding AIDS and HIV: A Comprehensive Overview
- HIV vs. AIDS: Understanding the Key Differences & Stages
- Thrush: Symptoms, Causes, and When to See a Doctor
- Understanding HIV Testing: Accuracy & Accessibility
